In vitro fertilization
is a process of giving birth which involves a series of operations by which an egg is fertilized by the sperm outside the body usually in the test tubes or glass containers. This process can be described as the mature eggs are collected from woman’s ovaries and fertilized by sperm in a lab. Then the fertilized egg (embryo) or eggs are implanted in the uterus. The fertilized egg is monitored for 2–6 days growth and then implanted in the uterus, with the intention of establishing a successful pregnancy. The baby who takes birth using process is called as test tube baby and this is mainly performed to overcome female infertility. IVF is a form of assisted reproductive technology (ART).The global IVF devices market
would witness a substantial growth in future owing to rising incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements. The global IVF devices and consumables market accounted for $XX billion in 2015 and is forecast to garner $XX billion by 2021, registering a promising CAGR of X% during the forecast period. The Asia-Pacific IVF services market was evaluated at $X billion in 2014 and is estimated to garner $XX billion by 2021.
There are some risks involved in the particular process such as Fallopian tube damage or blockage, Ovulation disorders, premature ovarian failure, Endometriosis, uterine fibroids, previous tubal sterilization or removal, impaired sperm production or function. Fertility preservation for cancer or other health conditions when there is a coagulation of eggs with sperm cells may also affect the baby health conditions.
The above table indicates the segmentation of in vitro fertilization services based on the method such as natural IVF, co incubation, embryo culture, Final maturation induction, Egg retrieval, Egg and sperm preparation etc., and also based on the instruments used such as incubators, micro manipulators, imaging system, cryosystem, Ovum aspiration pump, Sperm aspiration pump etc. The market is also segmented according to the end users and also on the expansion techniques and also on the geographical information. It also includes analysis about the various risks involved and also the various things that an IVF associate should cross check before this particular operation.
High costs keep IVF currently out of reach for many countries but the research by the Genk Institute for Fertility Technology, in Belgium; claims to have found a much lower cost methodology (about 90% reduction) with similar efficacy, which may be suitable for some type of fertility treatment.
Europe is the leading market for in vitro fertilization market with Ukraine and United Kingdom being the top countries opting for this procedure. Asia region is forecast to have highest growth in the next few years due to growing adoption of such technologies among the general population.